Company

About

Eligo Bioscience

Eligo Bioscience

Paris, France

Eligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing.

Nanobiotix

Nanobiotix

PARIS, France

Nanobiotix has been pioneering nanomedicine for more than 17 years to bring a different approach to medicine. Our therapeutic technologies are not based on biology or chemistry – they are based on physical principles at nanoscale. This paradigm shift has allowed us to discover novel approaches to improving treatment outcomes. Our company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. With this approach, our ambition is to benefit millions of patients who receive radiation therapy by improving the efficiency of radiation in tumor cells without increasing the dose received by surrounding healthy tissues. We believe that radiotherapy combined with NBTXR3 can become a new standard of care in the treatment of cancer. By viewing the human body through the lens of physics a new realm of possibilities has emerged.

NH TherAguix

NH TherAguix

Meylan, France

NH TherAguix is a biotech company registered at RCS Grenoble and based 19, Chemin des prés, 38240 Meylan

SUPERBRANCHE

SUPERBRANCHE

Strasbourg, France

SUPERBRANCHE : Nanomedicine as a breakthrough to treat cancer We bring answers to the following issue: intratumoral injection of nanomaterials implying both accessibility and detection of the tumor beforehand. We position ourselves as a producer dedicated to the synthesis of architectured nanomaterials as simple as possible and of controlled size. Our modular technology platform presents both therapeutic and diagnosis applications. It consists in a magnetic nanoparticle coated by a tailor made branched architecture. Thanks to their optimized shape and stability, our compounds are well tolerated and can be administered intravenously, thus helping to the early detection and treatment of metastases. The main advantage of the SUPERBRANCHE technology stem from our specific processes and synthesis know-how which are at the heart of our innovations. Superbranche is a Biotechnology company characterized by two main activities: - the sale of dendrimers and nanoparticles as research products to any laboratory in the field of nanomedicine - conducting development partnerships to bring to the clinics targeted diagnostic and image-guided therapy nanomaterials based on its proprietary technology.